Hypothermia and total body exsanguination: A cornerstone for the treatment of renal cell carcinoma with Grade IV vascular extension Sami ArapMarco A. ArapPaulo M. P. Fernandes Invited Commentary Pages: 259 - 260
Medical therapy for benign prostatic hyperplasia progression Kevin T. McVary OriginalPaper Pages: 269 - 275
Ethanol injection for the treatment of benign prostatic hyperplasia Edward D. Kim OriginalPaper Pages: 276 - 279
Changes in medicare reimbursement: Impact on therapy for benign prostatic hyperplasia Robert F. Donnell OriginalPaper Pages: 280 - 284
Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia? Mohamed A. GhafarPeter J. PuchnerRalph Buttyan OriginalPaper Pages: 292 - 296
Antibiotic therapy for chronic prostatitis/chronic pelvic pain syndrome Robert M. Moldwin Clinical Trials Report Pages: 299 - 299
Transurethral needle ablation and chronic nonbacterial prostatitis Robert M. Moldwin Clinical Trials Report Pages: 300 - 300
The NIH consensus concept of chronic prostatitis/chronic pelvic pain syndrome compared with traditional concepts of nonbacterial prostatitis and prostatodynia John N. KriegerSusan O. RossDonald E. Riley OriginalPaper Pages: 301 - 306
Theories of prostatitis etiology Matthew E. KarlovskyMichel A. Pontari OriginalPaper Pages: 307 - 312
Similarities between interstitial cystitis and male chronic pelvic pain syndrome Robert M. Moldwin OriginalPaper Pages: 313 - 318
Diagnosing the prostatitis patient: The dilemma continues Jeannette M. Potts OriginalPaper Pages: 319 - 323
Prostatitis and male infertility: Evidence and links Richard A. Schoor OriginalPaper Pages: 324 - 329
Phytotherapy and other alternative forms of care for the patient with prostatitis Daniel A. Shoskes OriginalPaper Pages: 330 - 334
